Showing results (1-10 of 91) with videos related to
Sort By:
Pageof 10
Current Opinion in Pharmacology|September 27, 2005
Parathyroid hormone - a bone anabolic and catabolic agentKenneth E S Poole, Jonathan ReeveStroke|May 4, 2002
Falls, fractures, and osteoporosis after stroke: time to think about protection?Kenneth E S Poole, Jonathan Reeve, Elizabeth A WarburtonOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2004
Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosisKenneth E S Poole, Elizabeth A Warburton, Jonathan ReeveStroke|March 31, 2007
A single infusion of zoledronate prevents bone loss after strokeKenneth E S Poole, Nigel Loveridge, Collette M Rose, et al.Stroke|December 3, 2005
Reduced vitamin D in acute strokeKenneth E S Poole, Nigel Loveridge, Peter J Barker, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 15, 2009
Changing structure of the femoral neck across the adult female lifespanKenneth E S Poole, Paul M Mayhew, Collette M Rose, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 27, 2005
Sclerostin is a delayed secreted product of osteocytes that inhibits bone formationKenneth E S Poole, Rutger L van Bezooijen, Nigel Loveridge, et al.Bone|January 6, 2009
Bone structure and remodelling in stroke patients: early effects of zoledronateKenneth E S Poole, Shobna Vedi, Irene Debiram, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 5, 2010
Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fractureJon Power, Kenneth E S Poole, Rutger van Bezooijen, et al.Pageof 10